Home › Compare › URAL vs EQR

URAL vs EQR: Dividend Comparison 2026

URAL yields 500000.00% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 URAL wins by $4.663521010693878e+33M in total portfolio value
10 years
URAL
URAL
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full URAL calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — URAL vs EQR

📍 URAL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodURALEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, URAL + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
URAL pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

URAL
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, URAL beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of URAL + EQR for your $10,000?

URAL: 50%EQR: 50%
100% EQR50/50100% URAL
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

URAL
No analyst data
Altman Z
-3.6
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

URAL buys
0
EQR buys
0
No recent congressional trades found for URAL or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricURALEQR
Forward yield500000.00% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$4.663521010693878e+33M$40.5K ✓
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓$3,819.61
Total dividends collected$4.6634009849658873e+33M$16.9K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: URAL vs EQR ($10,000, DRIP)

YearURAL PortfolioURAL Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,248$547.57+$50.00M → URAL
2$233,748,371,262$233,694,859,813.08$12,701$666.53+$233748.36M → URAL
3$1,021,074,511,412,696$1,020,824,400,655,446.10$14,405$814.59+$1021074511.40M → URAL
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$16,413$999.84+$4168597328794.94M → URAL
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$18,795$1,232.92+$15905475114600664.00M → URAL
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$21,639$1,527.95+$56718938532531060736.00M → URAL
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$25,057$1,903.80+$1.8903180743562385e+23M → URAL
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$29,197$2,385.87+$5.8879981047651824e+26M → URAL
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$34,250$3,008.70+$1.7140642681147225e+30M → URAL
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$40,467$3,819.61+$4.663521010693878e+33M → URAL

URAL vs EQR: Complete Analysis 2026

URAL — Stock

United Rail, Inc. focuses on the provision of upscale commuter Club X railcars for various state Department of Transportation municipal agencies. It owns outright 16 bi-level passenger railcars, as well as 2 leased cars. The company was formerly known as Las Vegas Railway Express, Inc. and changed its name to United Rail, Inc. in October 2018. The company is based in Las Vegas, Nevada.

Full URAL Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this URAL vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

URAL vs SCHDURAL vs JEPIURAL vs OURAL vs KOURAL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.